Why there’s an increase in gabapentinoid use

Increase in Gabapentinoid Use from 2015 to 2021

Increase in Gabapentinoid Use from 2015 to 2021

A recent study conducted between 2015 and 2021 has revealed a significant rise in the use of gabapentinoids. Gabapentinoids are a class of medications primarily used to treat epilepsy, neuropathic pain, and other related conditions.

The study, which analyzed data from various healthcare databases, found that the use of gabapentinoids increased steadily over the six-year period. This rise in usage was observed across different age groups and geographical regions.

Reasons for the Increase

Several factors may have contributed to the surge in gabapentinoid use. Firstly, the expanded recognition of neuropathic pain as a distinct condition has led to an increased demand for effective treatments. Gabapentinoids have shown promising results in managing neuropathic pain, leading to their wider prescription.

Additionally, the opioid epidemic has prompted healthcare providers to explore alternative pain management options. Gabapentinoids, with their non-opioid nature, have emerged as a viable alternative for pain relief, contributing to their increased utilization.

Implications and Concerns

While the rise in gabapentinoid use may indicate improved access to effective treatments, it also raises concerns regarding potential misuse and abuse. Studies have shown that gabapentinoids can produce euphoric effects when taken in high doses or combined with other substances.

Healthcare professionals need to be cautious when prescribing gabapentinoids and closely monitor patients for signs of misuse or dependence. Public health initiatives should also focus on educating individuals about the risks associated with gabapentinoid misuse.


The study’s findings highlight a significant increase in gabapentinoid use from 2015 to 2021. While this rise may be attributed to the growing recognition of neuropathic pain and the need for non-opioid pain management options, it also raises concerns about potential misuse and abuse.

Further research is necessary to better understand the long-term implications of gabapentinoid use and develop appropriate guidelines for their prescription. By striking a balance between providing effective treatment options and ensuring patient safety, healthcare professionals can optimize the use of gabapentinoids in the years to come.